Drug Type Small molecule drug |
Synonyms BRD 7929, BRD7929 |
Target |
Action inhibitors |
Mechanism PfPheRS inhibitors(P. falciparum PheRS inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H38N4O2 |
InChIKeyVKRCTZCBMKVHCK-RTOKGZNSSA-N |
CAS Registry1771650-41-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cryptosporidiosis | Preclinical | United States | 30 Sep 2020 | |
Cryptosporidiosis | Preclinical | United States | 30 Sep 2020 | |
Cryptosporidiosis | Preclinical | China | 30 Sep 2020 | |
Cryptosporidiosis | Preclinical | China | 30 Sep 2020 | |
Cryptosporidiosis | Preclinical | Netherlands | 30 Sep 2020 | |
Malaria | Preclinical | United States | 07 Sep 2016 | |
Malaria | Preclinical | United States | 07 Sep 2016 | |
Malaria | Preclinical | Japan | 07 Sep 2016 | |
Malaria | Preclinical | Netherlands | 07 Sep 2016 |